Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and … Read more
Aurinia Pharmaceuticals Inc (AUPH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.077x
Based on the latest financial reports, Aurinia Pharmaceuticals Inc (AUPH) has a cash flow conversion efficiency ratio of 0.077x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($44.57 Million) by net assets ($581.33 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aurinia Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Aurinia Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aurinia Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aurinia Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chongqing Fuling Electric Power Industrial Co Ltd
SHG:600452
|
0.064x |
|
Jiangsu Financial Leasing Co Ltd Class A
SHG:600901
|
-0.003x |
|
Ardentec
TWO:3264
|
0.049x |
|
Blackline Inc
NASDAQ:BL
|
0.072x |
|
VALIF
PINK:VALIF
|
N/A |
|
HARBOUR ENERGY LS 000002
F:PQQ0
|
N/A |
|
Marriot Vacations Worldwide
NYSE:VAC
|
0.025x |
|
Macrolink Real Estate Co Ltd
SHE:000620
|
0.008x |
Annual Cash Flow Conversion Efficiency for Aurinia Pharmaceuticals Inc (1998–2025)
The table below shows the annual cash flow conversion efficiency of Aurinia Pharmaceuticals Inc from 1998 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $581.33 Million | $135.66 Million | 0.233x | +98.45% |
| 2024-12-31 | $377.48 Million | $44.39 Million | 0.118x | +232.82% |
| 2023-12-31 | $377.95 Million | $-33.46 Million | -0.089x | +54.87% |
| 2022-12-31 | $405.44 Million | $-79.53 Million | -0.196x | +40.40% |
| 2021-12-31 | $479.09 Million | $-157.69 Million | -0.329x | -92.12% |
| 2020-12-31 | $407.75 Million | $-69.86 Million | -0.171x | +19.54% |
| 2019-12-31 | $298.60 Million | $-63.59 Million | -0.213x | +53.55% |
| 2018-12-31 | $112.58 Million | $-51.61 Million | -0.458x | -84.57% |
| 2017-12-31 | $165.74 Million | $-41.17 Million | -0.248x | +52.28% |
| 2016-12-31 | $35.95 Million | $-18.71 Million | -0.521x | +41.51% |
| 2015-12-31 | $19.96 Million | $-17.77 Million | -0.890x | -137.47% |
| 2014-12-31 | $45.11 Million | $-16.90 Million | -0.375x | -10.20% |
| 2013-12-31 | $13.30 Million | $-4.52 Million | -0.340x | -111.01% |
| 2012-12-31 | $-2.12 Million | $-6.55 Million | 3.090x | +1561.34% |
| 2011-12-31 | $6.41 Million | $-1.36 Million | -0.211x | +69.06% |
| 2010-12-31 | $6.35 Million | $-4.34 Million | -0.683x | +68.57% |
| 2009-12-31 | $4.81 Million | $-10.46 Million | -2.175x | +1.59% |
| 2008-12-31 | $7.87 Million | $-17.39 Million | -2.210x | -120.61% |
| 2007-12-31 | $28.41 Million | $-28.46 Million | -1.002x | +3.95% |
| 2006-12-31 | $20.17 Million | $-21.03 Million | -1.043x | -108.06% |
| 2005-12-31 | $42.36 Million | $-21.23 Million | -0.501x | -29.84% |
| 2004-12-31 | $52.20 Million | $-20.15 Million | -0.386x | -415.36% |
| 2003-12-31 | $68.54 Million | $-5.13 Million | -0.075x | -319.16% |
| 2002-12-31 | $47.56 Million | $-849.90K | -0.018x | +91.30% |
| 2001-12-31 | $35.28 Million | $-7.25 Million | -0.205x | +54.55% |
| 2000-12-31 | $12.76 Million | $-5.77 Million | -0.452x | -6.20% |
| 1999-12-31 | $3.19 Million | $-1.36 Million | -0.426x | -120.49% |
| 1998-12-31 | $-846.35K | $-1.76 Million | 2.077x | -- |